Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, C-MER Medical Holdings's Shareholder Yield % was 7.18%.
C-MER Medical Holdings (HKSE:03309) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
C-MER Medical Holdings Shareholder Yield % Related Terms
C-MER Medical Holdings Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for C-MER Medical Holdings's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:03309 vs HCA, THC, DVA: Shareholder Yield % Comparison
For the Medical Care Facilities subindustry, C-MER Medical Holdings's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
C-MER Medical Holdings Shareholder Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, C-MER Medical Holdings's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where C-MER Medical Holdings's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
C-MER Medical Holdings (HKSE:03309) has a Shareholder Yield % of 7.18% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on C-MER Medical Holdings and its competitors. According to the industry distribution chart, C-MER Medical Holdings ranks #103 out of 648 companies in the Healthcare Providers & Services industry, placing it in the top 15.9%.
Is C-MER Medical Holdings' Shareholder Yield % too high?
C-MER Medical Holdings' current Shareholder Yield % is 7.18%. The Healthcare Providers & Services industry median Shareholder Yield % is 0.25. C-MER Medical Holdings' value of 7.18% is 2830.6% above this industry median. Based on the distribution chart, C-MER Medical Holdings ranks #103 out of 648 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, C-MER Medical Holdings has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does C-MER Medical Holdings' Shareholder Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, C-MER Medical Holdings ranks #103 out of 648 companies for Shareholder Yield %. This places C-MER Medical Holdings in the top 16% of its industry — outperforming the majority of peers. The industry median Shareholder Yield % is 0.25. C-MER Medical Holdings' value of 7.18% is 2830.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Healthcare Providers & Services company?
The median Shareholder Yield % among Healthcare Providers & Services companies is 0.25, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. C-MER Medical Holdings's current Shareholder Yield % of 7.18% is 2830.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on C-MER Medical Holdings and its competitors. For the Healthcare Providers & Services industry, the median Shareholder Yield % is 0.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. C-MER Medical Holdings's current Shareholder Yield % is 7.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-MER Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, C-MER Medical Holdings (HKSE:03309) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.77, compared to a current price of HK$0.86 — trading 69.1% below its estimated fair value. The current Shareholder Yield % is 7.18% and 2830.6% above the Healthcare Providers & Services industry median of 0.25. C-MER Medical Holdings' overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For C-MER Medical Holdings (HKSE:03309), the current Shareholder Yield % is 7.18% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is C-MER Medical Holdings (HKSE:03309) Overvalued in 2026?
Based on GuruFocus' analysis, C-MER Medical Holdings stock appears to be undervalued.
The current stock price of HK$0.86 is trading 69.1% below its estimated GF Value™ of HK$2.77.
GuruFocus considers C-MER Medical Holdings to be Possible Value Trap.
Key valuation signals for HKSE:03309:
Shareholder Yield %: 7.18%
GF Value™: HK$2.77 vs. price of HK$0.86 (69.1% below fair value)
Industry Position: 2830.6% above the Healthcare Providers & Services median (#103 of 648)
No single metric tells the full story. See the HKSE:03309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
C-MER Medical Holdings Ltd is a ophthalmic medical chain group in Hong Kong and the Greater Bay Area. With ophthalmology as its core, it has gradually expanded its business scope to different specialist services. The company through its subsidiaries are principally engaged in the provision of ophthalmic, dental and other medical services, sales of vision aid products and sales of medical consumables in Hong Kong and Mainland China. Geographically, the company generates revenue from Mailand China, and Hong Kong, with the majority of revenue generated from Mainland China.
83GF Score
Get the complete analysis for HKSE:03309
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03309 has been successfully added to your 
